Understanding the Harms and Benefits of Cancer Screening

Medical Decision Making

Volumn 35, Issue 7, 2015, Pages 847-858

  Petrova, Dafina ^a,b   Garcia Retamero, Rocio ^a,b,c   Cokely, Edward T ^b,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

^c MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

Author keywords

cancer screening; emotions; risk communication; risk literacy; shared decision making

Indexed keywords

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COMPREHENSION; DECISION MAKING; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COMPREHENSION; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; YOUNG ADULT;

EID: 84941767500     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X15587676     Document Type: Article

References (66)

1. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch H,. Enthusiasm for cancer screening in the United States. JAMA. 2004; 291: 71-8.
2. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG,. US womens attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ. 2000; 320: 1635-40.
3. Hersch J, Jansen J, Barratt A, et al. Womens views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013; 346: f158.
4. Waller J, Douglas E, Whitaker KL, Wardle J,. Womens responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open. 2013; 3: e002703.
5. Gigerenzer G, Mata J, Frank R,. Public knowledge of benefits of breast and prostate cancer screening in Europe. J Nat Cancer Inst. 2009; 101: 1216-20.
6. Hoffman RM, Lewis CL, Pignone MP, et al. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making. 2010; 30: 53S-64S.
7. Sheridan SL, Harris RP, Woolf SH,. Shared decision making about screening and chemoprevention: a suggested approach from the US Preventive Services Task Force. Am J Prev Med. 2004; 26: 56-66.
8. Esserman LJ, Thompson IM, Reid B,. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013; 310: 797-8.
9. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH,. Informed decision making: what is its role in cancer screening? Cancer. 2004; 101: 1214-28.
10. Wegwarth O, Gigerenzer G,. €There is nothing to worry about€: gynecologists counseling on mammography. Patient Educ Couns. 2011; 84: 251-6.
11. Han PKJ, Kobrin S, Breen N, et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med. 2013; 11: 306-14.
12. Arkes HR, Gaissmaier W,. Psychological research and the prostate-cancer screening controversy. Psychol Sci. 2012; 23: 547-53.
13. Peters E,. Beyond comprehension: the role of numeracy in judgments and decisions. Curr Dir Psychol Sci. 2012; 21: 31-5.
14. Peters E, Dieckmann N, Dixon A, Hibbard JH, Mertz CK,. Less is more in presenting quality information to consumers. Med Care Res Rev. 2007; 64: 169-90.
15. Peters E, Hibbard J, Slovic P, Dieckmann N,. Numeracy skill and the communication, comprehension, and use of risk-benefit information. Health Aff. 2007; 26: 741-8.
16. Galesic M, Garcia-Retamero R,. Communicating consequences of risky behaviors: life expectancy versus risk of disease. Patient Educ Couns. 2011; 82: 30-35.
17. Nowak SA, Parker AM,. Social network effects of nonlifesaving early-stage breast cancer detection on mammography rates. Am J Public Health. 2014; 104: 2439-44.
18. Fagerlin A, Wang C, Ubel PA,. Reducing the influence of anecdotal reasoning on peoples health care decisions: is a picture worth a thousand statistics? Med Decis Making. 2005; 25: 398-405.
19. Gigerenzer G,. Breast cancer screening pamphlets mislead women. BMJ. 2014; 348: g2636.
20. Garcia-Retamero R, Wicki B, Cokely ET, Hanson B,. Factors predicting surgeons preferred and actual roles in interactions with their patients. Health Psychol. 2014; 33: 920-8.
21. Schwartz LM, Woloshin S, Black WC, Welch HG,. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997; 127: 966-72.
22. Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G,. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med. 2012; 156: 340-9.
23. Lipkus IM, Samsa G, Rimer BK,. General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001; 21: 37-44.
24. Galesic M, Garcia-Retamero R,. Statistical numeracy for health: a cross-cultural comparison with probabilistic national samples. Arch Intern Med. 2010; 170: 462-8.
25. Cokely ET, Galesic M, Schulz E, Ghazal S, Garcia-Retamero R,. Measuring risk literacy: the Berlin Numeracy Test. Judg Decis Making. 2012; 7: 25-47.
26. Reyna VF, Nelson WL, Han PK, Dieckmann NF,. How numeracy influences risk comprehension and medical decision making. Psychol Bull. 2009; 135: 943-73.
27. Trevena LJ, Zikmund-Fisher BJ, Edwards A, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Informat Decis Making. 2013; 13: S7.
28. Schwartz LM, Woloshin S, Welch HG,. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009; 150: 516-27.
29. Schwartz LM, Woloshin S, Welch HG,. The drug facts box: providing consumers with simple tabular data on drug benefit and harm. Med Decis Making. 2007; 27: 655-62.
30. Woloshin S, Schwartz LM, Welch HG,. The value of benefit data in direct-to-consumer drug ads. Health Aff. 2004; 23: 293-303.
31. Garcia-Retamero R, Cokely ET,. Communicating health risks with visual aids. Curr Dir Psychol Sci. 2013; 22: 392-9.
32. Galesic M, Garcia-Retamero R, Gigerenzer G,. Using icon arrays to communicate medical risks: overcoming low numeracy. Health Psychol. 2009; 28: 210-6.
33. Zikmund-Fisher BJ, Ubel PA, Smith DM, et al. Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns. 2008; 73: 209-14.
34. Gaissmaier W, Wegwarth O, Skopec D, Müller A, Broschinski S, Politi MC,. Numbers can be worth a thousand pictures: individual differences in understanding graphical and numerical representations of health-related information. Health Psychol. 2012; 31: 286-96.
35. Zikmund-Fisher BJ, Witteman HO, Dickson M, et al. Blocks, ovals, or people? Icon type affects risk perceptions and recall of pictographs. Med Decis Making. 2014; 34: 443-53.
36. Okan Y, Garcia-Retamero R, Cokely ET, Maldonado A,. Individual differences in graph literacy: overcoming denominator neglect in risk comprehension. J Behav Decis Making. 2012; 25: 390-401.
37. Garcia-Retamero R, Galesic M,. Who profits from visual aids: overcoming challenges in peoples understanding of risks. Soc Sci Med. 2010; 70: 1019-25.
38. Weinstein ND,. Perceived probability, perceived severity, and health-protective behavior. Health Psychol. 2000; 19: 65-74.
39. Rottenstreich Y, Hsee CK,. Money, kisses, and electric shocks: on the affective psychology of risk. Psychol Sci. 2001; 12: 185-90.
40. Pachur T, Hertwig R, Wolkewitz R,. The affect gap in risky choice: affect-rich outcomes attenuate attention to probability information. Decision. 2014; 1: 64.
41. Bandura A,. Perceived self-efficacy in cognitive development and functioning. Educ Psychol. 1993; 28: 117-48.
42. Kenny P, Quine S, Shiell A, Cameron S,. Participation in treatment decision-making by women with early stage breast cancer. Health Expect. 1999; 2: 159-68.
43. Say R, Murtagh M, Thomson R,. Patients preference for involvement in medical decision making: a narrative review. Patient Educ Couns. 2006; 60: 102-14.
44. Ilic D, Neuberger MM, Djulbegovic M, Dahm P,. Screening for prostate cancer. Cochrane Database Syst Rev. 2013; 1: CD004720.
45. Moyer VA,. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 120-34.
46. Finney Rutten LJ, Meissner HI, Breen N, Vernon SW, Rimer BK,. Factors associated with mens use of prostate-specific antigen screening: evidence from health information national trends survey. Prev Med. 2005; 40: 461-8.
47. Garcia-Retamero R, Müller SM, Catena A, Maldonado A,. The power of causal beliefs and conflicting evidence on causal judgments and decision making. Learn Motiv. 2009; 40: 284-97.
48. Lewandowsky S, Ecker UK, Seifert CM, Schwarz N, Cook J,. Misinformation and its correction continued influence and successful debiasing. Psychol Sci Pub Interest. 2012; 13: 106-31.
49. Garcia-Retamero R, Hoffrage U, Dieckmann A,. When one cue is not enough: combining fast and frugal heuristics with compound cue processing. Q J Exp Psychol. 2007; 60: 1197-215.
50. Garcia-Retamero R, Hoffrage U,. How causal knowledge simplifies decision-making. Mind Mach. 2006; 16: 365-380.
51. Gøtzsche PC, Jørgensen KJ,. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013; 6: CD001877.
52. Jolie A,. My medical choice. The New York Times. 2013. Available from: URL: http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html
53. Thackeray R, Burton SH, Giraud-Carrier C, Rollins S, Draper CR,. Using Twitter for breast cancer prevention: an analysis of breast cancer awareness month. BMC Cancer. 2013; 13: 508.
54. Garcia-Retamero R, Cokely ET,. Effective communication of risks to young adults: using message framing and visual aids to increase condom use and STD screening. J Exp Psychol Appl. 2011; 17: 270-87.
55. Rothman AJ, Martino SC, Bedell BT, Detweiler JB, Salovey P,. The systematic influence of gain-and loss-framed messages on interest in and use of different types of health behavior. Person Soc Psychol Bull. 1999; 25: 1355-69.
56. Garcia-Retamero R, Cokely ET,. The influence of skills, message frame, and visual aids on prevention of sexually transmitted diseases. J Behav Decis Making. 2014; 27: 179-89.
57. Deber RB, Kraetschmer N, Irvine J,. What role do patients wish to play in treatment decision making? Arch Intern Med. 1996; 156: 1414-20.
58. Hayes AF,. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-based Approach. New York: Guilford Press; 2008.
59. Zikmund-Fisher BJ, Fagerlin A, Ubel PA,. Improving understanding of adjuvant therapy options by using simpler risk graphics. Cancer. 2008; 113: 3382-90.
60. Payne JW,. Task complexity and contingent processing in decision making: an information search and protocol analysis. Organ Behav Hum Perform. 1976; 16: 366-87.
61. Olshavsky RW,. Task complexity and contingent processing in decision making: a replication and extension. Organ Behav Hum Perform. 1979; 24: 300-16.
62. Sharpe RE, Levin DC, Parker L, Rao VM,. The effect of the controversial US Preventive Services Task Force recommendations on the use of screening mammography. J Am Coll Radiol. 2013; 10: 21-4.
63. Deber RB, Kraetschmer N, Urowitz S, Sharpe N,. Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations. Health Expect. 2007; 10: 248-58.
64. Arora NK, McHorney CA,. Patient preferences for medical decision making: who really wants to participate? Med Care. 2000; 38: 335-41.
65. Paolacci G, Chandler J,. Inside the Turk: understanding Mechanical Turk as a participant pool. Curr Dir Psychol Sci. 2014; 23: 184-8.
66. Barratt A,. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality. BMJ. 2015; 350: h867.